The first batch of Russian COVID-19 vaccine- “Sputnik V”, developed by Russia’s Gamaleya National Center Covid, has arrived and more batches will be arriving and the vaccine is likely to be available in the market by next week, Dr. VK Paul, Member-Health of Niti Aayog said on Thursday.
The DCGI has accorded permission to conduct the Phase II-III clinical trial of Covaxin in the age group of two to 18-years-old to the Hyderabad based manufacturer Bharat Biotech International Ltd (BBIL). The trials will be conducted in 525 health volunteers
While the International Nurses Day was celebrated across India with felicitation of nurses with commendation certificates, by and large the nurses are over strained nurses, especially during ongoing COVID-19 pandemic and deserve better remuneration and working conditions.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
